73 related articles for article (PubMed ID: 15780504)
1. Secondary hyperparathyroidism promotes the acute phase response -- a rationale for supplemental vitamin D in prevention of vascular events in the elderly.
McCarty MF
Med Hypotheses; 2005; 64(5):1022-6. PubMed ID: 15780504
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
Yendt ER; Kovacs KA; Jones G
Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
[TBL] [Abstract][Full Text] [Related]
4. Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias?
McCarty MF; Barroso-Aranda J; Contreras F
Med Hypotheses; 2009 May; 72(5):581-3. PubMed ID: 19188028
[TBL] [Abstract][Full Text] [Related]
5. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature.
Jin J; Robinson AV; Hallowell PT; Jasper JJ; Stellato TA; Wilhem SM
Surgery; 2007 Dec; 142(6):914-20; discussion 914-20. PubMed ID: 18063076
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D.
McCarty MF
Med Hypotheses; 2000 Mar; 54(3):475-82. PubMed ID: 10783492
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
8. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
9. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Brown AJ; Slatopolsky E
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake.
Adami S; Viapiana O; Gatti D; Idolazzi L; Rossini M
Bone; 2008 Feb; 42(2):267-70. PubMed ID: 18024243
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
[TBL] [Abstract][Full Text] [Related]
13. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
Wolf M; Thadhani R
Semin Dial; 2005; 18(4):302-6. PubMed ID: 16076353
[TBL] [Abstract][Full Text] [Related]
14. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
Fisher L; Fisher A
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
[TBL] [Abstract][Full Text] [Related]
16. Statins do not affect mineral metabolism in chronic kidney disease: a retrospective analysis.
Ashman N; Banerjee A; Yaqoob MM
Nephron Clin Pract; 2009; 111(4):c236-9. PubMed ID: 19287183
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and impact of vitamin D insufficiency in southern Chinese adults.
Wat WZ; Leung JY; Tam S; Kung AW
Ann Nutr Metab; 2007; 51(1):59-64. PubMed ID: 17356256
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics.
Rejnmark L; Vestergaard P; Brot C; Mosekilde L
Clin Endocrinol (Oxf); 2008 Jul; 69(1):29-35. PubMed ID: 18208576
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute-phase response on nutritional status and clinical outcome of hospitalized patients.
Gariballa S; Forster S
Nutrition; 2006; 22(7-8):750-7. PubMed ID: 16815489
[TBL] [Abstract][Full Text] [Related]
20. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
